Lamotrigine Tablets — Class I drug recall D-0833-2020
Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2020-02-19, distributed nationwide. Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
| Recall number | D-0833-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States |
| Recall initiated | 2019-12-20 |
| Classified | 2020-02-07 |
| Reported by FDA | 2020-02-19 |
| Terminated | 2024-02-23 |
| Distributed | Nationwide (US) |
| NDC | 51672-4130, 51672-4130-00, 51672-4130-01, 51672-4130-03, 51672-4130-04, 51672-4130-06, 51672-4131, 51672-4131-00, 51672-4131-01, 51672-4131-03, 51672-4131-04, 51672-4131-06, 51672-4132, 51672-4132-00, 51672-4132-01, 51672-4132-02, 51672-4132-03, 51672-4132-04, 51672-4132-06, 51672-4133, 51672-4133-00, 51672-4133-01, 51672-4133-02, 51672-4133-03, 51672-4133-04 and 1 more |
| Lot numbers | 331771 |
| Expiration dates | 2021-06-20 |
Product
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
Reason for recall
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0833-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.